These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6980569)

  • 21. T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors.
    Wagner H; Hardt C; Heeg K; Pfizenmaier K; Solbach W; Bartlett R; Stockinger H; Röllinghoff M
    Immunol Rev; 1980; 51():215-55. PubMed ID: 7000672
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigen/mitogen induced cytolytic activity and IL-2 secretion in memory-like CTL-hybridomas.
    Kaufmann Y; Moscovitch M; Robb RJ; Rosenberg SA; Berke G
    Adv Exp Med Biol; 1985; 184():535-50. PubMed ID: 3929574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An attempt to produce "pre-T" cell hybridomas and to identify their antigens.
    Aihara Y; Bühring HJ; Aihara M; Klein J
    Eur J Immunol; 1986 Nov; 16(11):1391-9. PubMed ID: 3096743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble factors for B cell activation: a T cell hybridoma that secretes a specific B cell growth factor.
    Garchon HJ; Levi-Strauss M; Carnaud C; Bach JF
    J Immunol; 1983 Feb; 130(2):777-80. PubMed ID: 6600254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressor cells in neoplastic disease.
    Broder S; Muul L; Waldmann TA
    J Natl Cancer Inst; 1978 Jul; 61(1):5-11. PubMed ID: 353295
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. I. Functional characterization by monoclonal antibodies.
    MacDonald HR; Lees RK; Bron C
    J Immunol; 1985 Dec; 135(6):3944-50. PubMed ID: 2415592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thymoma--lymphocyte production and immunologic abnormality].
    Tamaoki N
    Nihon Rinsho; 1977; 35(10):3712-7. PubMed ID: 342746
    [No Abstract]   [Full Text] [Related]  

  • 28. Antigen-independent activation of cytotoxic T cells by lymphokines.
    Williams LD; McMaster WR; Teh HS
    Immunology; 1988 May; 64(1):121-8. PubMed ID: 3133307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of Cyclosporin A: inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas.
    Kaufmann Y; Chang AE; Robb RJ; Rosenberg SA
    J Immunol; 1984 Dec; 133(6):3107-11. PubMed ID: 6436374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One third of murine splenic T cells are cytotoxic precursors induced to grow by leucoagglutinin and TCGF.
    Larsson EL
    Scand J Immunol; 1981 May; 15(5):515-9. PubMed ID: 6980449
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of interleukin 2-dependent cytotoxic T-cell clones: specificity, cell surface phenotype, and susceptibility to blocking by Lyt antisera.
    Palladino MA; Obata Y; Stockert E; Oettgen HF
    Cancer Res; 1983 Feb; 43(2):572-6. PubMed ID: 6600215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human thymoma lymphocyte mitogenesis: glucocorticoid inhibitory capacity as a function of the size of the more mature T cell subset.
    Lauriola L; Musiani P; Ranelletti FO; Maggiano N; Piantelli M
    Clin Exp Immunol; 1983 Jun; 52(3):477-84. PubMed ID: 6603294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 2 is not sufficient as helper component for the activation of cytotoxic T lymphocytes but synergizes with a late helper effect that is provided by irradiated I-region-incompatible stimulator cells.
    Reddehase M; Suessmuth W; Moyers C; Falk W; Droege W
    J Immunol; 1982 Jan; 128(1):61-8. PubMed ID: 6172493
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological and biochemical properties of lymphokines produced by the EL 4 thymoma cell line.
    Benjamin WR; Farrar JJ
    Lymphokine Res; 1983; 2(1):33-6. PubMed ID: 6433117
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL; Fitch FW
    J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lectin-dependent cytolytic and cytolymic T helper clones and hybridomas.
    Lindahl KF; Nordin AA; Schreier MH
    Curr Top Microbiol Immunol; 1982; 100():1-10. PubMed ID: 6980086
    [No Abstract]   [Full Text] [Related]  

  • 39. [Activation of the membrane toxicity and cytotoxicity of the tumor cell by leukocyte and fibroblast interferon].
    Sterlina AG; Malinovskaia VV; Bogdashin IV; Fuks BB
    Biull Eksp Biol Med; 1982 Dec; 94(12):80-2. PubMed ID: 7150772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1.
    Hogarth PM; Potter TA; Cornell FN; McLachlan R; McKenzie IF
    J Immunol; 1980 Oct; 125(4):1618-24. PubMed ID: 6997382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.